Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12214218
Perfusion modulated tumor dose sculpting with single dose radiotherapy
granted -
US 12201658
Viral gene therapy as treatment for cholesterol storage disease or disorder
granted -
US 12201655
Antimicrobial therapy
granted -
US 12201719
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted -
US 12194061
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12194016
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 12186428
Combination taxoid nanoemulsion with immunotherapy in cancer
granted -
US 12186369
Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
granted -
US 2025002606
Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA
granted -
US 12178787
T cell receptors for immunotherapy
granted -
US 12173314
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12170134
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
granted -
US 12156879
Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy
granted -
US 12156863
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted -
US 12159700
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12151001
Optimized expression cassettes for gene therapy
granted -
US 12152242
CRISPR therapy
granted -
US 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted -
US 12121580
Antibacterial photodynamic therapy using copper-cysteamine nanoparticles
granted -
US 12121541
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 12110504
Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
granted -
US 12110334
Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy
granted